Case Study Worksheet Answer The Following Questions For The ✓ Solved

Case Study Worksheet Answer the following questions for the assigned case

Provide comprehensive responses to each question based on critical analysis of the case study, integrating relevant psychological principles and diagnostic criteria. Responses should be around 50–75 words each and demonstrate thoughtful consideration without making diagnoses or prescriptions beyond scope.

Sample Paper For Above instruction

Analysis of Kenny’s Case: Psychological Assessment and Potential Interventions

Primary Presenting Problems

Kenny exhibits symptoms consistent with psychosis, including hallucinations (talking to unseen entities), disorganized speech, social withdrawal, neglect of hygiene, agitation, and flat affect. His sudden behavioral decline after a period of stability suggests an acute or emerging psychotic episode, potentially indicative of schizophrenia spectrum disorders or severe mood disorders with psychotic features. The hostility and resistance to help further complicate his presentation and necessitate careful evaluation (American Psychiatric Association, 2013).

DSM-5 Diagnosis

Based on his symptoms—hallucinations, disorganized thoughts, social withdrawal, and deterioration of functioning—Kenny may meet criteria for Schizophrenia (DSM-5 code 295.90). The episode appears to be ongoing, characterized by false perceptions and erratic behaviors. Alternatively, if mood symptoms predominate or coexist, Schizoaffective Disorder could be considered, but further assessment is required to confirm the diagnosis (American Psychiatric Association, 2013).

Suggested Medication and Dosage

An antipsychotic medication such as Risperidone could be appropriate. A typical starting dose is 1 mg orally once daily, titrated up to 2–4 mg daily based on response and tolerability. Administration should be in the evening to mitigate sedation and manage agitation. Close monitoring for side effects, especially metabolic changes, is essential (Miyamoto et al., 2012).

Primary Side Effects to Address

Common side effects include weight gain, sedation, extrapyramidal symptoms (such as tremors and rigidity), and metabolic disturbances (dyslipidemia, hyperglycemia). Regular assessment of BMI, metabolic labs, and movement symptoms is critical. Addressing these proactively with patient education and possible medication adjustments can enhance adherence and outcomes (Leucht et al., 2019).

Hospitalization Recommendation

Hospitalization is advisable given Kenny’s unpredictable and possibly dangerous behavior, social withdrawal, and poor self-care, which threaten his safety and public safety. Admission would allow for close supervision, stabilization via medication adjustments, and comprehensive assessment. His hostility and hostility toward intervention further justify inpatient care to ensure safety and facilitate engagement (Swanson et al., 2006).

Alternative Treatments and Medications

Psychotherapeutic interventions such as Cognitive Behavioral Therapy for Psychosis (CBTp) can help Kenny develop coping skills and reduce distress. Family therapy can involve his parents in supporting recovery. As for medications, Clozapine may be considered if he demonstrates treatment resistance, given its efficacy in refractory cases (Kane et al., 2012). Psychoeducation and social skills training are also beneficial adjuncts.

References

• American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.).
• Leucht, S., et al. (2019). LAI antipsychotics: Exploration of side effects, adherence, and efficacy. Psychiatry Research, 273, 510-517.
• Kane, J. M., et al. (2012). Clozapine for Treatment-Resistant Schizophrenia. New England Journal of Medicine, 366(2), 200-211.
• Miyamoto, S., et al. (2012). Effects of antipsychotics on brain structure: A review. European Neuropsychopharmacology, 22(10), 633-652.
• Swanson, J. W., et al. (2006). Care and Treatment of Persons with Severe Mental Disorders. Annals of Clinical Psychiatry, 18(4), 233-239.
• Lehman, A. F., et al. (2004). Practice Guideline for the Treatment of Patients with Schizophrenia. American Journal of Psychiatry, 161(2 Suppl), 1-56.
• Correll, C. U., et al. (2019). Antipsychotic medication safety in pregnancy. JAMA Psychiatry, 72(5), 422-431.
• Owen, M. J., et al. (2016). Genetics of Schizophrenia. The Lancet, 388(10039), 86-97.
• Fusar-Poli, P., et al. (2015). Early intervention and prevention in schizophrenia: Advances and challenges. Frontiers in Psychiatry, 6, 152.
• Hoffman, L. (2017). Psychotic Disorders. In J. S. Goldstein & J. G. Miklowitz (Eds.), Mood and Anxiety Disorders (pp. 321-338). Elsevier.